<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="768019" id="root" date="1997-07-30" xml:lang="en">
<title>GERMANY: Altana eyes strong full-year profits after H1 data.</title>
<headline>Altana eyes strong full-year profits after H1 data.</headline>
<dateline>FRANKFURT 1997-07-30</dateline>
<text>
<p>German pharmaceuticals group Altana AG said on Wednesday it expected to post double digit sales and profits growth for the full year 1997 after the first half of the year got off to a strong start.</p>
<p>During the first six months of the year, sales climbed by 17 percent to 1.3 billion marks ($705.3 million) while pre-tax profits grew at a similarly robust pace to 114 million marks, Altana said.</p>
<p>The engines for growth were both acquisitions, contributing six percent to sales growth, and more favourable currency relationships, which added four percent to sales turnover, the group said in a statement.</p>
<p>Looking ahead to full year results, privately-held Altana predicted sales would reach 2.6 billion marks after 2.3 billion marks in 1996. For earnings, the group said &quot;from today's vantage point, we expect that profits will top last year's high level, maintaining a double-digit return on sales.&quot; ($ = 1.843 German Marks)  </p>
<p>Altana, however, differentiated between domestic and international sales, saying that efforts to cut health care costs had forced the group's domestic turnover down by three percent to 418 million marks.</p>
<p>The group's biggest business segment, pharmaceuticals, posted an eight percent rise in sales to 861 million marks, again boosted mainly by foreign sales.</p>
<p>Altana's gastrointestinal product Pantoprazol posted sales of 150 million marks in the first six months of 1997 after 80 million marks during the same time a year earlier.</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="GFR">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-07-30"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I25700">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-07-30"/>
  </code>
  <code code="I83960">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-07-30"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C15">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-07-30"/>
  </code>
  <code code="C151">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-07-30"/>
  </code>
  <code code="C152">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-07-30"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-07-30"/>
  </code>
</codes>
<dc element="dc.date.created" value="1997-07-30"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1997-07-30"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="FRANKFURT"/>
<dc element="dc.creator.location.country.name" value="GERMANY"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
